• Home
  •  
    Regions
    • Europe
    • UK & Ireland
    • DACH
    • Nordic
    • France
    • Southern Europe
    • Benelux
    • CEE
    • Asia
  •  
    Deals
    • Buyouts
    • Venture
    • Exits
    • Refinancings
    • Build-up
    • Turnaround
    • Secondaries
    • Advanced deals search
  •  
    Funds
    • Buyout
    • Venture
    • Mezzanine
    • Debt
    • Funds-of-funds
    • Secondaries
    • Fundraising pipelines
    • Advanced funds search
  •  
    GPs & LPs
    • GP profiles
    • LP profiles
    • GP news
    • LP news
    • Sponsors search
    • LPs search
  •  
    Secondaries
    • Deals
    • Funds
    • News
    • Analysis
  •  
    People
    • People moves
    • Analysis
    • In Profile
    • Q&A
    • Videos
    • Comment
  •  
    Analysis
    • In Profile
    • Fundraising
    • Q&A
    • Comment
    • Videos
    • Podcast
    • Reports
    • Data Snapshots
  •  
    Unquote Data
    • Deals search
    • Exits search
    • Funds search
    • Sponsors search
    • Advisers search
    • LPs search
    • League tables
    • Reports
  • Sign in
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)203 741 1137

      Email: Georgina.Lawson@acuris.com

      • Sign in
     
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • Twitter
    • LinkedIn
  • Free Trial
  • Subscribe
Unquote
Unquote
  • Home
  • Regions
  • Deals
  • Funds
  • GPs & LPs
  • Secondaries
  • People
  • Analysis
  • Unquote Data
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)203 741 1137

    Email: Georgina.Lawson@acuris.com

    • Sign in
 
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 

healthcare

Healthtech investments
Spex Capital launches EUR 100m early-stage healthtech fund

New GP has sights set on further impact vehicles such as food and climate technology

  • Venture
  • 27 February 2023
Human microbiome
Seventure preps third generation of microbiome fund

Health for Life III to be slightly larger than EUR 250m predecessor; will invest in Europe, US, Israel

  • Venture
  • 06 February 2023
German healthcare
German health minister’s 'locust sponsors' comments spook live healthcare deals

New entrants scared by remarks on limiting profits; existing investors expected to rush to complete bolt-ons

  • Buyouts
  • 25 January 2023
Laser eye surgery
H2 turns to bilateral talks to get Optegra sale over the line, sources say

Deal with MidEuropa sealed after auction for ophthalmology group went quiet earlier this month

  • Exits
  • 30 November 2022
Drugs production lines
Novalpina fund exits Laboratoire XO to Stanley Capital

French drug maker is the first divestment from liquidated fund Novalpina I, now managed by Berkeley Research Group

  • Exits
  • 04 October 2022
Closes of funds in euros
EQT closes new European tech growth-stage fund on EUR 2.2bn

Closed above target, the new vehicle has raised a total of EUR 2.4bn in commitments

  • Buyout
  • 12 September 2022
Pharma-focused fundraises
Ampersand closes USD 1.2bn healthcare fund for US, EU deployment

Fundraise follows hiring push in Europe; GP typically deploys USD 10m-50m tickets in primary buyouts

  • Buyout
  • 24 August 2022
Pharma-focused fundraises
SHS nears EUR 250m hard cap on sixth fund

Healthcare fund’s EUR 200m target exceeded in first close with commitments from around 60 LPs

  • Healthcare
  • 21 July 2022
Pharmacies and drugs retailers
Five Arrows exits pharmacy group Laf Sante to Latour

Vendor plans to reinvest in pharmacy chain; Bpifrance takes minority stake

  • Healthcare
  • 13 July 2022
Pharma-focused fundraises
Forbion exceeds Growth Opportunities II target with EUR 470m first close

Biopharma GP sees growing demand for private capital amid IPO lull; gears up for EUR 600m hard-cap by summer end

  • Venture
  • 09 June 2022
Rafaele Tordjman of Jeito Capital
VC Profile: Jeito Capital in final stretch of biotech fund deployment

Founder Rafaèle Tordjman outlines the French sponsor’s strategy as it aims to remain independent amid wave of consolidation in healthcare funds

  • GPs
  • 13 May 2022
Doctor in online medical video conference
QPE backs MBO of Republic M!

The buyout of the British commercial services outsourcer is QPE's seventh platform deal under its maiden fund

  • Media
  • 11 May 2022
Doctor consultation via video link
Teachers' Venture Growth leads Alan's EUR 183m Series E

Temasek, Index, Coatue, Ribbit Capital, Exor, Dragoneer, and Lakestar also joined the round which values Alan at EUR 2.7bn

  • Expansion
  • 05 May 2022
Vaccines and injections
Astorg beats sponsors to acquire CordenPharma

The sponsor competed with Advent International in the final round of an auction led by William Blair

  • Healthcare
  • 03 May 2022
Fundraising in the UK
Cambridge Innovation Capital raises GBP 225m for Fund II

The VC firm's first closed-end fund will invest in Series A rounds of deep-tech and life science companies connected to Cambridge

  • Funds
  • 25 April 2022
Laser eye surgery
GBL bags second healthcare asset this week with SBO of Sanoptis

Vendor Telemos to fully exit DACH eye clinics operator following auction that also saw ICG and Ares compete for the asset

  • Healthcare
  • 20 April 2022
Doctors and consultants
GBL acquires Affidea from B-Flexion

Formerly known as Waypoint, vendor is fulling exiting the pan-European outpatient group; new owner will invest EUR 1bn in equity

  • Healthcare
  • 19 April 2022
Biotech drug discovery companies
Novo-backed ReViral acquired by Pfizer

The British biotech company is also backed by CR-CP, New Leaf, Andera Partners, and OrbiMed, among others

  • Healthcare
  • 08 April 2022
Seeing a specialist healthcare fundraising soared in the last decade
Specialist healthcare funds on track for another record year

GPs raised EUR 4.4bn with swelling need for healthcare investment but could face challenges in keeping a disciplined deployment

  • Data Snapshot
  • 06 April 2022
Biotech drug discovery companies
Jeito, INKEF, Forbion lead EUR 80m Series B for Precirix

Precirix last raised a EUR 37m Series A in 2018

  • Healthcare
  • 16 March 2022
Fundraising in euros
Gilde Healthcare closes fourth buyout fund on EUR 517m

Double the size of its predecessor, the new vehicle was oversubscribed and saw nearly all Gilde’s existing LPs investing

  • Healthcare
  • 16 March 2022
Dermatologist examining a patient
Ufenau moves Corius and Altano to continuation fund

Bought in 2017, the dermatology and vet groups have been transferred into the Swiss GP’s third continuation vehicle

  • Secondaries
  • 15 March 2022
Disability care and education
Queen's Park Equity backs Blue Ribbon MBO

The deal is the sixth from QPE's Equity Fund I

  • Buyouts
  • 14 March 2022
Healthcare equipment
Limerston exits Prism to Charme

Charme will complete the deal through Charme IV, which has raised EUR 700m to date

  • Healthcare
  • 03 March 2022
1 2 3

Most read

Andy Gregory of BGF
GP Profile: BGF to deploy GBP 500m-plus per year for minority growth deals with entrepreneurs
Credit Suisse Headquarters building and UBS building to the left Paradeplatz Bahnhofstrasse Zurich
European sponsors sidestep panic, concede gloom over bank woes
Influencers and social media
Inflexion sells The Goat Agency to trade, nets 80% IRR
Online learning courses
Synova kicks off new fund deployment with Learnlight acquisition
Marek Moravec of Nation 1
Nation 1 launches new early-stage, EUR 35m-EUR 40m fund
  • About Unquote
  • Advertise
  • Contacts
  • About Acuris
  • Terms of Use
  • Privacy Policy
  • Group Disclaimer
  • Twitter
  • LinkedIn

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013